Hartland & Co »

Anika Therapeutics shares owned by Hartland & Co

Quarter-by-quarter ownership of Anika Therapeutics (ANIK) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Anika Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Anika Therapeutics held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anika Therapeutics by Hartland & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $300 32 9.41
2025-06-30 $465 44 10.59

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs Put Option (Principal) (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Apple (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Value Etf (VTV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
NVIDIA Corporation (NVDA)
Wisdomtree Tr Us Largecap Divd (DLN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Hartland & Co

Top funds holding Anika Therapeutics

BlackRock
Trigran Investments
Caligan Partners
Vanguard Group
Acadian Asset Management
Dimensional Fund Advisors
Capital Management Corporation
Boothbay Fund Management
Renaissance Technologies
Geode Capital Management
State Street Corporation
D. E. Shaw & Co
Envestnet Asset Management
Northern Trust
Jacobs Levy Equity Management

View all funds holding Anika Therapeutics